CK Life Sciences Int'l. (Holdings) Inc

F:LSI Germany Biotechnology
Market Cap
$853.37 Million
€831.36 Million EUR
Market Cap Rank
#14695 Global
#1512 in Germany
Share Price
€0.09
Change (1 day)
-0.57%
52-Week Range
€0.05 - €0.11
All Time High
€0.11
About

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; m… Read more

CK Life Sciences Int'l. (Holdings) Inc (LSI) - Total Liabilities

Latest total liabilities as of June 2025: €7.63 Billion EUR

Based on the latest financial reports, CK Life Sciences Int'l. (Holdings) Inc (LSI) has total liabilities worth €7.63 Billion EUR as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CK Life Sciences Int'l. (Holdings) Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how CK Life Sciences Int'l. (Holdings) Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

CK Life Sciences Int'l. (Holdings) Inc Competitors by Total Liabilities

The table below lists competitors of CK Life Sciences Int'l. (Holdings) Inc ranked by their total liabilities.

Liability Composition Analysis (2013–2024)

This chart breaks down CK Life Sciences Int'l. (Holdings) Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.68 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CK Life Sciences Int'l. (Holdings) Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CK Life Sciences Int'l. (Holdings) Inc (2013–2024)

The table below shows the annual total liabilities of CK Life Sciences Int'l. (Holdings) Inc from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 €7.28 Billion +3.10%
2023-12-31 €7.06 Billion -0.75%
2022-12-31 €7.11 Billion -1.64%
2021-12-31 €7.23 Billion -0.40%
2020-12-31 €7.26 Billion +11.00%
2019-12-31 €6.54 Billion +8.66%
2018-12-31 €6.02 Billion +3.29%
2017-12-31 €5.83 Billion +14.63%
2016-12-31 €5.08 Billion -3.24%
2015-12-31 €5.25 Billion -3.11%
2014-12-31 €5.42 Billion +8.03%
2013-12-31 €5.02 Billion --